# Atlantis Health

> Atlantis Health designs and delivers personalized patient engagement and behavior change programs for pharmaceutical, biotech and healthcare organizations. Its work combines health psychology, patient co-design, digital platforms and human support to help people begin and continue treatment and manage long-term conditions.

- **Founded:** 1996
- **Headquarters:** Summit, United States
- **Founders:** Michael Whittaker (Co-founder; former CEO), Jonny Duder (Co-founder; CEO), Hamish Franklin (Co-founder), Sarah Walsh (Co-founder)
- **Products:** Patient engagement strategy and co-design, Patient Engagement Platform, Patient Engagement Platform App for Salesforce, Digital Coach / Ria, Patient Support App
- **Notable:** SmartSight support-program participants showed 88% two-year treatment persistence versus 64% in a separate Australian PBS comparison sample; observational comparison, not randomized proof., A 2026 psoriatic disease case study reports 83% twelve-month persistence versus a 64% literature benchmark., Its AbbVie Rheumatology Care Patient Workbook won a 2013 Communiqué Award for Writing Excellence.

## Products & services

- **Patient engagement strategy and co-design** — Behavioral research, experience mapping and collaborative design of patient support and clinical trial engagement services.
- **Patient Engagement Platform** — Configurable journeys, patient profiling and reporting across digital and nurse support.
- **Patient Engagement Platform App for Salesforce** — Behavior Change as a Service content and workflows inside Salesforce-based patient support operations.
- **Digital Coach / Ria** — Customizable digital coaching with behavioral content; current service material includes governed AI support.
- **Patient Support App** — Personalized medication information, reminders and check-ins.
- **Medication Access** — Digital support for newly diagnosed people accessing cost-effective medications online.
- **Human support services** — Contact center coaching, nurse services and medication delivery coordination; availability varies by market.

## Achievements

- SmartSight support-program participants showed 88% two-year treatment persistence versus 64% in a separate Australian PBS comparison sample; observational comparison, not randomized proof.
- A 2026 psoriatic disease case study reports 83% twelve-month persistence versus a 64% literature benchmark.
- Its AbbVie Rheumatology Care Patient Workbook won a 2013 Communiqué Award for Writing Excellence.
- The September 2026 rare blood cancer case study reports localized toolkits in 30+ countries and 35,000+ annual unique website visitors.

## Latest updates

- **2026-09** — Published a global rare blood cancer support case study, describing co-created tools and localized rollout.
- **2026-04** — Published an integrated patient support case study for psoriasis and psoriatic arthritis.
- **2026-03** — Published an oncology engagement and adherence discussion with Dr. Kate Perry.
- **2025-11** — Presented intentional cancer-treatment nonadherence research at ESPACOMP 2025.

## Links

- Website: https://atlantishealth.com/
- LinkedIn: https://www.linkedin.com/company/atlantis-health
- Twitter/X: https://twitter.com/AtlantisHtweets
- Facebook: https://facebook.com/Atlantis-Healthcare-US-200079240495259/

---

Profile page: https://yespress.io/atlantis-health
Published by YesPress — https://yespress.io
Last updated: 2026-10-01